Table 36.
Change in prevalence of IBD between 2015 and 2025.
| Analysis |
Annual Percentage Change (95% CI) |
2015 | 2025 | ||||
|---|---|---|---|---|---|---|---|
| Prevalence per 100,000 | # of people with IBD | Total cost | Prevalence per 100,000 | # of people with IBD | Total cost | ||
| Canada | |||||||
| CD | 3.75∗ (2.57, 4.93) | 400 | 143,645 | $761,387,855 | 578 | 227,795 | $1,494,819,111 |
| UC | 1.74 (−0.02, 3.54) | 260 | 93,163 | $493,809,045 | 309 | 121,566 | $797,730,230 |
| IBD | 2.79∗ (1.68, 3.91) | 660 | 236,807 | $1,255,196,900 | 887 | 349,361 | $2,292,549,341 |
|
| |||||||
| USA | |||||||
| CD | 3.27∗ (0.17, 6.53) | 259 | 831,994 | $8,772,936,478 | 357 | 1,240,590 | $17,053,678,379 |
| UC | 1.66 (−1.12, 4.51) | 275 | 883,669 | $5,711,328,062 | 324 | 1,125,494 | $9,483,218,424 |
| IBD | 2.25∗ (0.07, 4.48) | 534 | 1,715,663 | $14,484,264,540 | 681 | 2,366,083 | $26,536,896,803 |
|
| |||||||
| North America | |||||||
| CD | 2.67∗ (1.33, 4.03) | 273 | 975,639 | $9,534,324,334 | 380 | 1,468,384 | $18,548,497,490 |
| UC | 1.86∗ (0.40, 3.34) | 273 | 976,832 | $6,205,137,106 | 322 | 1,247,059 | $10,280,948,654 |
| IBD | 2.39∗ (1.39, 3.41) | 547 | 1,952,470 | $15,739,461,440 | 702 | 2,715,444 | $28,829,446,144 |
∗Denotes significant increase.